Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05861076 · ClinicalTrials.gov registry record · NA

Moringa Powder Acceptability Trial Among Healthy Adults

A NA study of Acceptability and Side Effect, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT05861076 is a NA study of Acceptability and Side Effect that has completed, run by University of California, Berkeley. The registered enrollment target is 52 participants, above the 47-participant average among 4 other Acceptability trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05861076, a NA study of Acceptability and Side Effect, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The study is a randomized acceptability trial involving the provision of three different doses of Moringa powder to be consumed daily by study participants.

Interventions

  • OTHER Moringa Powder - Low Dose
  • OTHER Moringa Powder - Medium Dose
  • OTHER Moringa Powder - High Dose

Study Locations (1)

California

  • University of California - Berkeley

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-01-03
Est. Completion 2023-05-30
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT05861076

The ClinicalTrials.gov registry entry for NCT05861076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 47-participant average among 4 other Acceptability trials with a reported enrollment target (11% higher). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Acceptability appearing as the primary indexed condition, and to 3 interventions - of which Moringa Powder - Low Dose is the first listed.

NCT05861076 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05861076 about?

NCT05861076 is a clinical study titled "Moringa Powder Acceptability Trial Among Healthy Adults". The study is a randomized acceptability trial involving the provision of three different doses of Moringa powder to be consumed daily by study participants.

What is the current status of trial NCT05861076?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2023-01-03. Estimated completion is 2023-05-30.

What conditions does trial NCT05861076 study?

This clinical trial studies the following conditions: Acceptability, Side Effect, Consumption.

What interventions are being tested in trial NCT05861076?

The interventions under investigation include: Moringa Powder - Low Dose (OTHER), Moringa Powder - Medium Dose (OTHER), Moringa Powder - High Dose (OTHER).

Who is sponsoring clinical trial NCT05861076?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05861076 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acceptability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.